Cargando…
Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment
Type 1 diabetes is a chronic illness in which the native beta (β)-cell population responsible for insulin release has been the subject of autoimmune destruction. This condition requires patients to frequently measure their blood glucose concentration and administer multiple daily exogenous insulin i...
Autores principales: | Mahoney, Alexandra L. G., Nassif, Najah T., O’Brien, Bronwyn A., Simpson, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315695/ https://www.ncbi.nlm.nih.gov/pubmed/35883588 http://dx.doi.org/10.3390/cells11142145 |
Ejemplares similares
-
Pancreatic Transdifferentiation and Glucose-Regulated Production of Human Insulin in the H4IIE Rat Liver Cell Line
por: Ren, Binhai, et al.
Publicado: (2016) -
Ex Vivo Expansion of Murine MSC Impairs Transcription Factor-Induced Differentiation into Pancreatic β-Cells
por: Gerace, Dario, et al.
Publicado: (2019) -
Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice
por: La, Que T., et al.
Publicado: (2020) -
Reversal of diabetes following transplantation of an insulin-secreting human liver cell line: Melligen cells
por: Lawandi, Janet, et al.
Publicado: (2015) -
Targeting the PI3K/Akt signaling pathway in pancreatic β‐cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes
por: Camaya, Inah, et al.
Publicado: (2022)